Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia

• Status: Completed
• Trial end date: 2017-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Androgenetic alopecia (AGA) is a common form of hair loss in both men and women, characterized by progressive patterned loss of hair from the scalp. The current study has been designed for restoration of hair in AGA by using a combination of stromal vascular fraction (derived from the adipose tissue) and human platelet rich plasma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: King Edward Medical University

Criteria

Inclusion Criteria:

• Patients 15 year or older

• Both males and females

• Patients diagnosed as male AGA, type III to VI using Hamilton - Norwood classification, as female pattern hair loss type I-III using Ludwig classification

• Active hair loss within last 12 months.

• Patients receiving fitness certificate from fitness committee (Medical Specialist, Plastic Surgeon and Anesthetist)

Exclusion Criteria:

• Pregnancy

• Diabetes

• Malignancy

• Global scalp hair thinning including occipital areas

• Patients with scalp inflammation, scalp infection (bacterial, viral, fungal and protozoal)

• Patients on anticoagulant therapy

• Patient on chemotherapy during the last five years